Hasenkamp, J., & Witzens-Harig, M. (2014). Minimum tolerable interval of radioimmunotherapy and autologous stem cell transplantation after high-dose chemotherapy for relapsed or refractory aggressive B cell Non-Hodgkin-Lymphoma provides excellent disease control. Blood, 124(21), .
Chicago-Zitierstil (17. Ausg.)Hasenkamp, Justin, und Mathias Witzens-Harig. "Minimum Tolerable Interval of Radioimmunotherapy and Autologous Stem Cell Transplantation After High-dose Chemotherapy for Relapsed or Refractory Aggressive B Cell Non-Hodgkin-Lymphoma Provides Excellent Disease Control." Blood 124, no. 21 (2014).
MLA-Zitierstil (9. Ausg.)Hasenkamp, Justin, und Mathias Witzens-Harig. "Minimum Tolerable Interval of Radioimmunotherapy and Autologous Stem Cell Transplantation After High-dose Chemotherapy for Relapsed or Refractory Aggressive B Cell Non-Hodgkin-Lymphoma Provides Excellent Disease Control." Blood, vol. 124, no. 21, 2014.